Make a donation

Friday, July 26 2019

Darzalex Now Listed in Saskatchewan!

As of July 15, Darzalex (daratumumab) has been approved in Saskatchewan, in combination with lenalidomide and dexamethasone (DRd regimen) or bortezomib and dexamethasone (DVd regimen) for the treatment of patients with multiple myeloma with good performance status who have received at least one prior therapy.

Consult the Drug Formulary